Peanut Allergy
📧 Sign up to get email alerts when something new happens for Peanut Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
The study evaluated the allergenicity of a hypoallergenic peanut product in peanut-allergic subjects. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2015-02-20Clinical Trial Update: Xolair Enhances Oral Desensitization in Peanut Allergic Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Xolair (omalizumab) in peanut-allergic patients has completed with posted results, suggesting enhanced…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Study of Tolerance to Oral Peanut [Phase 1]
A Phase 1 trial evaluating tolerance to oral peanut in individuals with peanut allergy has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy [NA]
This update notes the completion of a clinical trial studying how the immune system responds to viruses in children with peanut allergy who …
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance
This update summarizes immunologic findings in children with severe peanut and tree nut allergies after induction of tolerance, based on the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults [Phase 1]
A Phase 1 peanut allergy vaccine trial in healthy and peanut-allergic adults has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: A Safety and Efficacy Study of Xolair in Peanut Allergy [Phase 2]
Phase 2 safety and efficacy trial of Xolair (omalizumab) for peanut allergy has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization [Phase 2]
A Phase 2 pilot trial is evaluating whether ketotifen reduces adverse events during peanut desensitization in children. The study status is …
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy [Phase 1]
A Phase 1 safety update on epicutaneous immunotherapy for peanut allergy, reporting safety data from DBV Technologies' approach.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g [Phase 2]
Phase 2 study evaluating Xolair (omalizumab) in peanut-allergic subjects; the trial has completed and results were posted in 2009.